Heideveld Esther, Horcas-Lopez Marta, Lopez-Yrigoyen Martha, Forrester Lesley M, Cassetta Luca, Pollard Jeffrey W
MRC Centre for Reproductive Health, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Methods Enzymol. 2020;632:113-131. doi: 10.1016/bs.mie.2019.10.005. Epub 2019 Nov 18.
Tumor-associated macrophages (TAMs) are becoming a promising target for cancer immunotherapy. Significant efforts have been made to study the detrimental role of TAMs both in vivo and in vitro. However, it remains challenging to isolate these macrophages to study their function in human cancers and there is the need to seek alternatives to address these limitations. In this review, we will focus on the three most relevant approaches to obtain in vitro fully differentiated macrophages i.e. peripheral blood, immortalized cell lines such as THP-1 or human induced pluripotent stem cells. We will also provide protocols for the polarization of human macrophages to a TAM-like cells in vitro.
肿瘤相关巨噬细胞(TAM)正成为癌症免疫治疗的一个有前景的靶点。人们已付出巨大努力在体内和体外研究TAM的有害作用。然而,分离这些巨噬细胞以研究它们在人类癌症中的功能仍然具有挑战性,因此需要寻找替代方法来克服这些限制。在本综述中,我们将重点关注三种最相关的获取体外完全分化巨噬细胞的方法,即外周血、永生化细胞系(如THP-1)或人类诱导多能干细胞。我们还将提供体外将人类巨噬细胞极化为TAM样细胞的方案。